Source: Annual Congress 2010 - Asthma: breath biomarkers and asthma control
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Pejkovska, G. Breskovska, S. Arbutina, Z. Arsovski, K. Busletic (Skopje, Fyrom). Patients with mild to moderate asthma may develop clinically significant chronic obstructive pulmonary disease. Eur Respir J 2010; 36: Suppl. 54, 1296

Member's Comments

No comment yet.

Related content which might interest you: Are severe asthma and chronic obstructive pulmonary disease the same disease? Source: Annual Congress 2006 - Smoking asthmatics – a neglected population? Year: 2006 Subclinical cardiac dysfunction in moderate to severe chronic obstructive pulmonary disease (COPD) patients Source: Annual Congress 2011 - COPD management Year: 2011 The safety of sputum induction in patients with exacerbation of severe and very severe COPD (chronic obstructive pulmonary disease) Source: Annual Congress 2008 - Organisation of care and management of COPD Year: 2008 Can we predict the outcomes of treatment of patients with severe exacerbation of chronic obstructive pulmonary disease (COPD)? Source: Eur Respir J 2001; 18: Suppl. 33, 241s Year: 2001 The impact of using different symptom-based exacerbation algorithms in patients with COPD Source: Eur Respir J 2011; 37: 1260-1268 Year: 2011 Antibiotics in the exacerbations of severe and very severe chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD Year: 2008 Prevelance of anemia in patients with COPD Source: Annual Congress 2006 - COPD comorbidity Year: 2006 Renal function reserve in patients with mild and moderate chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 56s Year: 2005 Smoking and dyspnea severity in patients with chronic obstructive pulmonary disease Source: International Congress 2017 – Passive smoking and epidemiology Year: 2017 The characteristic of chronic renal dysfunction in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 The efficacy and side-effects of varenicline in patients with mild to moderate chronic obstructive pulmonary diseases Source: Annual Congress 2010 - Passive smoking Year: 2010 Cognitive performance in patients with chronic obstructive pulmonary disease at moderate altitude Source: Annual Congress 2010 - Advances in lung function II Year: 2010 The impact of anemia of chronic disease on exercise capacity among patients with chronic obstructive pulmonary disease Source: Annual Congress 2011 - Clinical physiology for clinical problems Year: 2011 The food frequency in patients with chronic obstructive pulmonary disease: effect of exacerbation of disease Source: Eur Respir J 2006; 28: Suppl. 50, 624s Year: 2006 Prevalence of bronchiectasis in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 60s Year: 2006 Prevalence of anemia of chronic disease in patients with chronic obstructive pulmonary disease Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity Year: 2011 The impact of anemia on patients with chronic obstructive pulmonary disease in the community Source: Annual Congress 2012 - Distinguishing phenotypes and dealing with comorbidities in primary care Year: 2012 Bronchiectasis impact outcomes in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD Year: 2008 Influence of bronchodilators on pulmonary hypertension (PH) in patients with moderate and severe chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2005; 26: Suppl. 49, 310s Year: 2005 High interleukin-33 is associated with acute exacerbation in patients with chronic obstructive pulmonary disease Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases Year: 2020